KeyVexKeyVex
Sign in
KeyVex › Disclosures › Executive-branch trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Rahul Gupta, N Director, National Drug Control Policy, Office of National Drug Control Policy, disclosed 1 transaction

· Executive-branch trades · U.S. Office of Government Ethics (Form 278-T)

2022-01-26 · saleWalmart, Inc. — $15,001 - $50,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

ownerself
sourceOGE_278T
tickerWMT
notifiedfalse
filing idoge-278t-rahul-gupta-2022-02-02-1
amount max50000
amount min15001
asset nameWalmart, Inc.
filer nameRahul Gupta
filer typeappointee
report urlhttps://extapps2.oge.gov/201/Presiden.nsf/PAS+Index/C2202539AAD78BD0852587FF0033C425/$FILE/Rahul-Gupta-02.02.2022-278T.pdf
scraped at2026-06-02T23:33:26.833Z
filing date2022-02-02
amount range$15,001 - $50,000
filer positionN Director, National Drug Control Policy, Office of National Drug Control Policy
transaction date2022-01-26
transaction typesale

Original filing document